Sangamo Therapeutics Inc (SGMO) earnings · rev $39.6M
These earnings events as JSON? API free 100/daySangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
This SGMO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SGMO revenue for 2025-12-31 was $39.6M. Net income was -$122.9M. Revenue was down 31.6% from 2024-12-31 to 2025-12-31. SGMO currently screens at market cap $74.6M.
When the next SGMO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 31.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full SGMO research stays on the stock page; the tape stays on the quote page.
SGMO earnings FAQ
What are SGMO's latest revenue and net income?
Latest cached Sangamo Therapeutics Inc (SGMO) revenue for Dec 31, 2025 was $39.6M. Net income was -$122.9M. Statements: https://lician.com/financials/sgmo
What is SGMO's latest diluted EPS?
Latest cached Sangamo Therapeutics Inc (SGMO) diluted EPS for Dec 31, 2025 was -$0.44.
What period does the latest SGMO earnings print cover?
The latest cached Sangamo Therapeutics Inc (SGMO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did SGMO revenue change from the prior cached period?
Cached Sangamo Therapeutics Inc (SGMO) revenue was down 31.6% from $57.8M (Dec 31, 2024) to $39.6M (Dec 31, 2025). Statements: https://lician.com/financials/sgmo
Where are SGMO earnings listed?
Cached earnings facts for Sangamo Therapeutics Inc (SGMO) are listed at https://lician.com/earnings/sgmo. Statements: https://lician.com/financials/sgmo
Not investment advice.